启明星 | 全球通用自动驾驶第一股文远知行成功登陆纳斯达克 | Bilingual

企业   2024-10-25 23:01   上海  


(请左右滑动查看双语新闻稿)


北京时间10月25日,启明创投投资企业、全球领先的自动驾驶科技公司文远知行WeRide成功登陆纳斯达克,至此文远知行成为全球通用自动驾驶第一股,也是全球Robotaxi第一股。文远知行(NASDAQ:WRD)发行价为15.5美元/ADS,市值43亿美元。

 


作为科技与创新的紧密连接者,启明创投长期关注自动驾驶领域的创新和变革。启明创投是文远知行最早的投资人,目前也是公司占比最大的财务投资人,早在2017年,启明创投投资文远知行种子轮融资,随后在A轮、B轮不断支持公司的发展。

 

文远知行成立于2017年,致力于开发安全可靠的自动驾驶技术,已经在全球7个国家30个城市开展自动驾驶研发、测试及运营,运营天数超过1700天,是唯一同时拥有中国、阿联酋、新加坡、美国四地自动驾驶牌照的科技企业。目前,文远知行形成了自动驾驶出租车(Robotaxi)、自动驾驶小巴(Robobus)、自动驾驶货运车(Robovan)、自动驾驶环卫车(Robosweeper)、高阶智能驾驶(Advanced Driving Solution)等五大产品矩阵,应用场景覆盖智慧出行、智慧货运和智慧环卫。


 

文远知行在技术研发、商业化和企业管理等方面都拥有丰富的海内外实践经验,已与多家全球顶级主机厂和一级供应商、物流和城市服务提供商达成战略合作伙伴关系,包括雷诺日产三菱联盟、宇通集团、博世、广汽集团等。目前文远知行在自动驾驶商业化方面的探索位居领导地位,根据灼识咨询的数据显示,文远知行是全球首家累计意向订单量突破1万辆L4级自动驾驶汽车的公司,也是唯一一家在18个月内实现ADAS解决方案量产的自动驾驶公司,速度在同行业中位居前列。

 

文远知行开发了WeRide One自动驾驶通用技术平台,以自研的自动驾驶全栈式软件算法为核心,涵盖自动驾驶模块化硬件解决方案以及自动驾驶云架构平台,通过三大层级全面打通“研发一部署一应用”的自动驾驶产品生命周期,让文远知行的技术得以规模化地应用于更加广泛的产品和场景当中。

 

文远知行创始人兼CEO韩旭表示:“文远知行从成立之初,就致力于以无人驾驶改变人类出行。感谢启明创投在文远知行发展初期就选择与我们并肩前行,长期陪伴直至见证今天的里程碑。上市是公司发展的一个新起点,接下来文远知行将继续坚持技术产品化、产品商业化的发展路径,把安全、舒适、便捷的自动驾驶技术、产品和服务带给更多国家和地区的用户。”

 

启明创投创始主管合伙人邝子平表示:“作为文远知行最早的投资人,有幸见证了公司从一个想法逐步成长为行业的领军者,在这一过程中,文远知行的团队充分表现出了创业者的坚韧,对科技改变世界梦想的坚持,以及在无人驾驶方面的世界一流水平。上市是公司发展历程中的重要里程碑,更是全新旅程的起点。期望文远知行未来继续不断革新技术,源源不断地打造优质产品,加快实现自动驾驶技术的广泛运用,造福人类。启明创投也将持之以恒地支持类似文远知行这样的企业在这些领域不断创新和创造。”

Qiming Venture Partners Celebrates WeRide's IPO on Nasdaq


On October 25th, 2024, Beijing Time, WeRide, a world-leading autonomous driving company and Qiming Venture Partners' portfolio company, began trading on Nasdaq. This marks a historic milestone as both the world's first pure-play autonomous driving company to go public and the first publicly listed Robotaxi company. WeRide (NASDAQ:WRD) offered at $15.5/ADS, representing a market cap of $4.3 billion.

 

Qiming Venture Partners, a leading venture firm committed to frontier technology investments, has long recognized the transformative potential of autonomous driving technology for society. As the earliest and largest financial investor in WeRide, Qiming has played a pivotal role in the company's growth, participating in its Series Seed, A, and B funding rounds since 2017.

 

Established in 2017, WeRide aims to develop safe and reliable autonomous driving solutions. The company is the only tech company in the world that simultaneously holds autonomous driving permits in China, the UAE, Singapore, the US, conducting autonomous driving R&D, tests and operations in over 30 cities of 7 countries around the world. WeRide has operated a self-driving fleet for more than 1,700 days.

 

As the pioneer in autonomous driving technologies with applications in the passenger transportation, intra-city delivery and urban sanitation industries, WeRide offers an all-rounded product mix of Robotaxi, Robobus, Robovan, Robosweeper, and Advanced Driving solution.

 

With rich experience in autonomous driving R&D, commercialization and operation, WeRide has forged strong alliances with world-class vehicle manufacturers, Tier 1 suppliers, logistics and urban service providers and others, including Renault-Nissan-Mitsubishi Alliance, Yutong Group, BOSCH, GAC Group, etc. Currently, WeRide has demonstrated its leadership in the commercialization of autonomous driving technology. According to China Insights Consultancy, WeRide is the first autonomous driving company in the world to accumulate 10,000 purpose-built L4 autonomous driving vehicle intent orders, and the only autonomous driving company to achieve mass production of an ADAS solution within 18 months into development, the quickest among its peers.

 

WeRide has developed the highly compatible autonomous driving solution platform, WeRide One, which constitutes a full stack of industry-leading application software, a flexible set of hardware and a comprehensive infrastructure software platform. This approach seamlessly connects the entire lifecycle of autonomous driving products, from R&D through deployment to application. The platform is designed to enable scalable implementation of WeRide's technology across a diverse range of products and scenarios.

 

Tony Han, Founder and CEO of WeRide, stated, "Since its inception, WeRide has been dedicated to transforming urban living with autonomous driving. We are grateful to Qiming Venture Partners for choosing to stand by us during the early stages of WeRide's development, offering long-term support up to the milestone we celebrate today. The IPO marks a new beginning for the company's growth. Moving forward, WeRide will continue to adhere to its path of productizing technology and commercializing products, bringing safe, comfortable, and convenient autonomous driving technologies, products, and services to users in more countries and regions."

 

Duane Kuang, Founding Managing Partner of Qiming Venture Partners, stated, "As the earliest investor in WeRide, we're proud to have witnessed the company's transformation from a concept into an industry leader. Over the years, the WeRide team has demonstrated remarkable resilience and commitment to using their world-class autonomous driving technology to improve the world. This IPO represents a significant milestone and the beginning of a new chapter for WeRide. We are confident in WeRide's continued innovation and its role in accelerating the development of autonomous driving applications for the benefit of humanity. Qiming remains dedicated to supporting visionary companies like WeRide in the smart mobility sector and its ecosystem."

往 期 回 顾


启明星 | 文远知行发布全新量产Robotaxi GXR | Bilingual
启明观点 | 启明创投邝子平:对中国科技创新与科技创投保持信心
启明星 | 中国领先的智能音视频服务提供商七牛云成功登陆香港主板 | Bilingual

启明创投成立于2006年。目前,启明创投旗下管理11只美元基金,7只人民币基金,已募管理资产总额达到95亿美元。自成立至今,专注于投资科技及消费(Technology and Consumer, T&C)、医疗健康(Healthcare)等行业早期和成长期的优秀企业。

截至目前,启明创投已投资超过530家高速成长的创新企业,其中有超过200家分别在美国纽交所、纳斯达克,香港交易所,上交所及深交所等交易所上市,或通过并购等方式退出,有70多家企业成为行业公认的独角兽或超级独角兽企业。

启明创投投资企业中,很多已经成长为各自领域中最具影响力的公司,包括小米集团(01810.HK)、美团(03690.HK)、哔哩哔哩(NASDAQ:BILI, 09626.HK)、知乎(NYSE:ZH, 02390.HK)、石头科技(688169.SH)、优必选(09880.HK)、文远知行(NASDAQ:WRD)、甘李药业(603087.SH)、泰格医药(300347.SZ, 03347.HK)、再鼎医药(NASDAQ:ZLAB, 09688.HK)、康希诺生物(688185.SH, 06185.HK)、Schrödinger(NASDAQ:SDGR)、惠泰医疗(688617.SH)、诺辉健康(06606.HK)、三友医疗(688085.SH)、艾德生物(300685.SZ)、贝瑞基因(000710.SZ)、神州细胞(688520.SH)、圆心科技、康缔亚、信念医药、壁仞科技等。


启明创投
成立于2006年,启明创投以卓越的投资业绩在中国风险投资界享有盛誉。
 最新文章